Your fact-checks will appear here
Use of intracavernosal injections for treating erectile dysfunction after prostatectomy.
Vacuum erection devices (VEDs) are a noninvasive, well‑established treatment for erectile dysfunction (ED) with consistently reported low long‑term morbidity and high continuation/satisfaction rates i...
Early penile rehabilitation is commonly recommended after radical prostatectomy, but exact timing varies by modality and by clinician; many centers start oral PDE5 inhibitors at the time the catheter ...
PDE5 inhibitors are the established first‑line therapy for ED with roughly 60–70% initial response and substantial evidence that chronic/daily use can help preserve or improve long‑term erectile funct...
Randomized trials exist for each modality—PDE5 inhibitors (PDE5i), vacuum erection devices (VED), and intracavernosal injections (ICI)—and several randomized studies and systematic reviews report bene...
Combination penile-rehabilitation protocols—typically a vacuum erectile device (VED) plus a phosphodiesterase‑5 inhibitor (PDE5i), or combinations that include intracavernosal injections (ICI)—general...
Vacuum erection devices (VEDs), oral phosphodiesterase‑5 inhibitors (PDE5i), and intracavernosal injections are all established ED therapies with different mechanisms, strengths, and trade‑offs: oral ...
A large clinician‑measured meta‑analysis puts average flaccid penis girth at about 9.31 cm (3.66–3.67 in) and average erect girth at about 11.66 cm (4.59 in) based on pooled measurements of over 15,00...